Efficacy and tolerability of entacapone in patients with Parkinson's disease treated with levodopa plus a dopamine agonist and experiencing wearing-off motor fluctuations. A randomized, double-blind, multicentre study

G. F�nelon; S. Gim�nez-Rold�n; J. L. Montastruc; F. Bermejo; F. Durif; I. Bourdeix; J.-J. P�r�; L. Galiano; J. Schadrack

doi:10.1007/s00702-002-0799-z

Efficacy and tolerability of entacapone in patients with Parkinson's disease treated with levodopa plus a dopamine agonist and experiencing wearing-off motor fluctuations. A randomized, double-blind, multicentre study

Journal of Neural Transmission ◽

10.1007/s00702-002-0799-z ◽

2003 ◽

Vol 110 (3) ◽

pp. 239-251 ◽

Cited By ~ 35

Author(s):

G. F�nelon ◽

S. Gim�nez-Rold�n ◽

J. L. Montastruc ◽

F. Bermejo ◽

F. Durif ◽

...

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Multicentre Study ◽

Dopamine Agonist ◽

Motor Fluctuations ◽

Double Blind ◽

Wearing Off

Download Full-text

Efficacy, safety, and tolerance of the non-ergoline dopamine agonist pramipexole in the treatment of advanced Parkinson's disease: a double blind, placebo controlled, randomised, multicentre study

Journal of Neurology Neurosurgery & Psychiatry ◽

10.1136/jnnp.66.4.436 ◽

1999 ◽

Vol 66 (4) ◽

pp. 436-441 ◽

Cited By ~ 95

Author(s):

M M Pinter ◽

O Pogarell ◽

W H Oertel

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Multicentre Study ◽

Dopamine Agonist ◽

Double Blind ◽

Advanced Parkinson’S Disease ◽

Double Blind Placebo

Download Full-text

Faculty Opinions recommendation of Extended-release carbidopa-levodopa (IPX066) compared with immediate-release carbidopa-levodopa in patients with Parkinson's disease and motor fluctuations: a phase 3 randomised, double-blind trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717995409.793474520 ◽

2013 ◽

Author(s):

Cynthia Comella

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Extended Release ◽

Immediate Release ◽

Motor Fluctuations ◽

Double Blind Trial ◽

Phase 3 ◽

Double Blind ◽

Blind Trial

Download Full-text

Early combination therapy with levodopa and dopamine agonist for preventing motor fluctuations in Parkinson's disease

10.1002/14651858.cd001311 ◽

1998 ◽

Author(s):

Geneviève Durrieu

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Combination Therapy ◽

Dopamine Agonist ◽

Motor Fluctuations ◽

Early Combination Therapy

Download Full-text

Adjunct rasagiline to treat Parkinson’s disease with motor fluctuations: a randomized, double-blind study in China

Translational Neurodegeneration ◽

10.1186/s40035-018-0119-7 ◽

2018 ◽

Vol 7 (1) ◽

Cited By ~ 6

Author(s):

Zhenxin Zhang ◽

Ming Shao ◽

Shengdi Chen ◽

Chunfeng Liu ◽

Rong Peng ◽

...

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Motor Fluctuations ◽

Blind Study ◽

Double Blind Study ◽

Double Blind

Download Full-text

P2.098 Saflnamide as an adjunct to levodopa signiflcantly improved motor fluctuations in Parkinson's disease: a phase III, randomized, double-blind, placebo-controlled study

Parkinsonism & Related Disorders ◽

10.1016/s1353-8020(09)70449-3 ◽

2009 ◽

Vol 15 ◽

pp. S115

Author(s):

R. Borgohain ◽

J. Szasz ◽

M. Bhatt ◽

S. Rossetti ◽

V. Lucini ◽

...

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Motor Fluctuations ◽

Phase Iii ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Efficacy of opicapone in Parkinson’s disease patients with ‘early’ motor fluctuations: Patient and clinical global impression of change from the BIPARK-I double-blind experience

Journal of the Neurological Sciences ◽

10.1016/j.jns.2019.10.1151 ◽

2019 ◽

Vol 405 ◽

pp. 191-192

Author(s):

F. Rocha ◽

F. Stocchi ◽

A. Lees ◽

J. Ferreira ◽

W. Poewe ◽

...

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Clinical Global Impression ◽

Motor Fluctuations ◽

Double Blind ◽

Global Impression Of Change

Download Full-text

Incidence of treatment-emergent adverse events in Parkinson's disease patients according to baseline dopamine agonist use: Post-hoc analysis from double-blind combined BIPARK-I and II data

Journal of the Neurological Sciences ◽

10.1016/j.jns.2019.10.1168 ◽

2019 ◽

Vol 405 ◽

pp. 200-201

Author(s):

R. Costa ◽

A. Lees ◽

J. Ferreira ◽

O. Rascol ◽

F. Stocchi ◽

...

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Adverse Events ◽

Dopamine Agonist ◽

Double Blind ◽

Post Hoc Analysis ◽

Post Hoc

Download Full-text

Pardoprunox as adjunct therapy to levodopa in patients with Parkinson’s disease experiencing motor fluctuations: Results of a double-blind, randomized, placebo-controlled, trial

Parkinsonism & Related Disorders ◽

10.1016/j.parkreldis.2011.12.006 ◽

2012 ◽

Vol 18 (4) ◽

pp. 370-376 ◽

Cited By ~ 22

Author(s):

O. Rascol ◽

J. Bronzova ◽

R.A. Hauser ◽

A.E. Lang ◽

C. Sampaio ◽

...

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Controlled Trial ◽

Motor Fluctuations ◽

Double Blind ◽

Adjunct Therapy

Download Full-text

Extended-release carbidopa-levodopa (IPX066) compared with immediate-release carbidopa-levodopa in patients with Parkinson's disease and motor fluctuations: a phase 3 randomised, double-blind trial

The Lancet Neurology ◽

10.1016/s1474-4422(13)70025-5 ◽

2013 ◽

Vol 12 (4) ◽

pp. 346-356 ◽

Cited By ~ 120

Author(s):

Robert A Hauser ◽

Ann Hsu ◽

Sherron Kell ◽

Alberto J Espay ◽

Kapil Sethi ◽

...

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Extended Release ◽

Immediate Release ◽

Motor Fluctuations ◽

Double Blind Trial ◽

Phase 3 ◽

Double Blind ◽

Blind Trial

Download Full-text

Faculty Opinions recommendation of Extended-release carbidopa-levodopa (IPX066) compared with immediate-release carbidopa-levodopa in patients with Parkinson's disease and motor fluctuations: a phase 3 randomised, double-blind trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717995409.793473992 ◽

2013 ◽

Author(s):

Werner Poewe ◽

Philipp Mahlknecht

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Extended Release ◽

Immediate Release ◽

Motor Fluctuations ◽

Double Blind Trial ◽

Phase 3 ◽

Double Blind ◽

Blind Trial

Download Full-text